3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Lymphoma, Follicular
1
Hemophilia A
1
Coagulation Protein Disorders
1
Blood Coagulation Disorders
1
Interventions
Cyclophosphamide
31
fludarabine phosphate
28
Mycophenolic Acid
21
Cyclosporine
21
Peripheral Blood Stem Cell Transplantation
19
Whole-Body Irradiation
17
Antilymphocyte Serum
17
Cord Blood Stem Cell Transplantation
15
Busulfan
15
Tacrolimus
13
Radiotherapy
11
Filgrastim
11
Methotrexate
9
Methylprednisolone
8
Melphalan
8
fludarabine
6
Etoposide
5
Epoetin Alfa
5
Cytarabine
4
Thiotepa
3
Therapeutics
3
Darbepoetin alfa
3
thymoglobulin
2
merphos
2
Vorinostat
2
Immunoenzyme Techniques
2
Granulocyte Colony-Stimulating Factor
2
Flow Cytometry
2
Cyclosporins
2
Bortezomib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
BIVV001
×
Classical hematology
×
Clear all
NCT06716814
2026-04-20
LIBERTY
Swedish Orphan Biovitrum
Phase 3
Recruiting
104 enrolled